Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-24

FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd)

View source ↗

Summary

The FDA approved a supplemental application for amitriptyline hydrochloride by Advagen Pharma Ltd, indicating an approved change to an already authorized produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amitriptyline hydrochloride (amitriptyline hydrochloride)

Snippet

SUPPL AP for AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE)